Work

ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate (IM) for primary and recurrent operable malignant GIST: Imaging findings and correlation with genotype and GLUT4 expression

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.10552

Authors: A. D. Van den Abbeele, C. Gatsonis, D. J. de Vries, Y. Melenevsky, A. Szot Barnes, J. T. Yap, A. K. Godwin, M. Blevins, B. Eisenberg, B. A. Siegel

Institutions: Dartmouth–Hitchcock Medical Center, Fox Chase Cancer Center, Brown University, Dana-Farber Cancer Institute

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2563738604

Cites:

Cited by:

Related to: 10